136 related articles for article (PubMed ID: 11557360)
1. Design and structure-activity relationship of thrombin inhibitors with an azaphenylalanine scaffold: potency and selectivity enhancements via P2 optimization.
Zega A; Mlinsek G; Sepic P; Golic Grdadolnik S; Solmajer T; Tschopp TB; Steiner B; Kikelj D; Urleb U
Bioorg Med Chem; 2001 Oct; 9(10):2745-56. PubMed ID: 11557360
[TBL] [Abstract][Full Text] [Related]
2. Exploring the chiral space within the active site of alpha-thrombin with a constrained mimic of D-Phe-Pro-Arg--design, synthesis, inhibitory activity, and X-ray structure of an enzyme-inhibitor complex.
Hanessian S; Balaux E; Musil D; Olsson LL; Nilsson I
Bioorg Med Chem Lett; 2000 Feb; 10(3):243-7. PubMed ID: 10698445
[TBL] [Abstract][Full Text] [Related]
3. The synthesis of azapeptidomimetic beta-lactam molecules as potential protease inhibitors.
Malachowski WP; Tie C; Wang K; Broadrup RL
J Org Chem; 2002 Dec; 67(25):8962-9. PubMed ID: 12467415
[TBL] [Abstract][Full Text] [Related]
4. Novel morpholinone-based D-Phe-Pro-Arg mimics as potential thrombin inhibitors: design, synthesis, and X-ray crystal structure of an enzyme inhibitor complex.
Dahlgren A; Johansson PO; Kvarnström I; Musil D; Nilsson I; Samuelsson B
Bioorg Med Chem; 2002 Jun; 10(6):1829-39. PubMed ID: 11937341
[TBL] [Abstract][Full Text] [Related]
5. Molecular recognition at the thrombin active site: structure-based design and synthesis of potent and selective thrombin inhibitors and the X-ray crystal structures of two thrombin-inhibitor complexes.
Obst U; Banner DW; Weber L; Diederich F
Chem Biol; 1997 Apr; 4(4):287-95. PubMed ID: 9195869
[TBL] [Abstract][Full Text] [Related]
6. 1,2-disubstituted cyclohexane derived tripeptide aldehydes as novel selective thrombin inhibitors.
Harmat NJ; Di Bugno C; Criscuoli M; Giorgi R; Lippi A; Martinelli A; Monti S; Subissi A
Bioorg Med Chem Lett; 1998 May; 8(10):1249-54. PubMed ID: 9871744
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and in vitro evaluation of new azaphenylalanine derivatives as serine protease inhibitors.
Obreza A; Stegnar M; Trampus-Bakija A; Prezelj A; Urleb U
Pharmazie; 2004 Oct; 59(10):739-43. PubMed ID: 15544050
[TBL] [Abstract][Full Text] [Related]
8. Peptide-derived transition state analogue inhibitors of thrombin; synthesis, activity and selectivity.
Jetten M; Peters CA; Visser A; Grootenhuis PD; van Nispen JW; Ottenheijm HC
Bioorg Med Chem; 1995 Aug; 3(8):1099-114. PubMed ID: 7582983
[TBL] [Abstract][Full Text] [Related]
9. New tripeptidic thrombin inhibitors. Influence of P2 and P3 residues on activity and selectivity.
De Nanteuil G; Gloanec P; Lila C; Portevin B; Boudon A; Rupin A; Verbeuren TJ
Bioorg Med Chem; 1995 Aug; 3(8):1019-24. PubMed ID: 7582976
[TBL] [Abstract][Full Text] [Related]
10. In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design.
Costanzo MJ; Almond HR; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Corcoran TW; Giardino EC; Kauffman JA; Lewis JM; de Garavilla L; Haertlein BJ; Maryanoff BE
J Med Chem; 2005 Mar; 48(6):1984-2008. PubMed ID: 15771442
[TBL] [Abstract][Full Text] [Related]
11. Structure-based design and optimization of potent renin inhibitors on 5- or 7-azaindole-scaffolds.
Matter H; Scheiper B; Steinhagen H; Böcskei Z; Fleury V; McCort G
Bioorg Med Chem Lett; 2011 Sep; 21(18):5487-92. PubMed ID: 21840215
[TBL] [Abstract][Full Text] [Related]
12. Crystallographic structure of a peptidyl keto acid inhibitor and human alpha-thrombin.
Håkansson K; Tulinsky A; Abelman MM; Miller TA; Vlasuk GP; Bergum PW; Lim-Wilby MS; Brunck TK
Bioorg Med Chem; 1995 Aug; 3(8):1009-17. PubMed ID: 7582975
[TBL] [Abstract][Full Text] [Related]
13. Novel non-covalent azaphenylalanine thrombin inhibitors with an aminomethyl or amino group at the P1 position.
Obreza A; Stegnar M; Urleb U
Pharmazie; 2004 Sep; 59(9):659-67. PubMed ID: 15497744
[TBL] [Abstract][Full Text] [Related]
14. D-Phe-Pro-Arg type thrombin inhibitors: unexpected selectivity by modification of the P1 moiety.
Lange UE; Baucke D; Hornberger W; Mack H; Seitz W; Höffken HW
Bioorg Med Chem Lett; 2003 Jun; 13(12):2029-33. PubMed ID: 12781189
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of diversely substituted azacyclic inhibitors of endothelin converting enzyme.
Hanessian S; Gauchet C; Charron G; Marin J; Nakache P
J Org Chem; 2006 Mar; 71(7):2760-78. PubMed ID: 16555831
[TBL] [Abstract][Full Text] [Related]
16. Amide and alpha-keto carbonyl inhibitors of thrombin based on arginine and lysine: synthesis, stability and biological characterization.
Brady SF; Sisko JT; Stauffer KJ; Colton CD; Qiu H; Lewis SD; Ng AS; Shafer JA; Bogusky MJ; Veber DF
Bioorg Med Chem; 1995 Aug; 3(8):1063-78. PubMed ID: 7582980
[TBL] [Abstract][Full Text] [Related]
17. The beta-turn scaffold of tripeptide containing an azaphenylalanine residue.
Lee HJ; Park HM; Lee KB
Biophys Chem; 2007 Jan; 125(1):117-26. PubMed ID: 16890344
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity study of tripeptide thrombin inhibitors using alpha-alkyl amino acids and other conformationally constrained amino acid substitutions.
Shuman RT; Rothenberger RB; Campbell CS; Smith GF; Gifford-Moore DS; Paschal JW; Gesellchen PD
J Med Chem; 1995 Oct; 38(22):4446-53. PubMed ID: 7473571
[TBL] [Abstract][Full Text] [Related]
19. Rational design and characterization of D-Phe-Pro-D-Arg-derived direct thrombin inhibitors.
Figueiredo AC; Clement CC; Zakia S; Gingold J; Philipp M; Pereira PJ
PLoS One; 2012; 7(3):e34354. PubMed ID: 22457833
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of novel thrombin inhibitors. Use of ring-closing metathesis reactions for synthesis of P2 cyclopentene- and cyclohexenedicarboxylic acid derivatives.
Thorstensson F; Kvarnström I; Musil D; Nilsson I; Samuelsson B
J Med Chem; 2003 Mar; 46(7):1165-79. PubMed ID: 12646027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
